OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in HIV and AIDS is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Editorial introductions	116
The sounds of silencing: dynamic epigenetic control of HIV latency	79
Future options for long-acting HIV treatment and prevention	37
Updates on bone health in people living with HIV: global impact, prediction tools, and treatment	32
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission	31
Integrating socio-behavioral, ethics, community, and translational science considerations in HIV cure research	29
HIV-associated tuberculosis in infants, children, and adolescents younger than 15 years: an update on the epidemiology, diagnosis, prevention, and treatment	27
Advancing HIV cure: insights from developing chronic hepatitis b therapies for functional cure	27
Statins for primary cardiovascular disease prevention among people with HIV: emergent directions	26
A behavioral economics approach to enhancing HIV preexposure and postexposure prophylaxis implementation	26
Harnessing natural killer cells to target HIV-1 persistence	26
Impact of early antiretroviral therapy, early life immunity and immune sex differences on HIV disease and posttreatment control in children	26
Editorial introduction	24
Editorial introduction	22
Editorial introduction	21
Fc-mediated immunological mechanisms in HIV infection: a better understanding for improved therapeutic approaches	21
New latency-promoting agents for a block-and-lock functional cure strategy	18
Loneliness and social isolation in people with HIV	18
Development of screening assays for use of broadly neutralizing antibodies in people with HIV	18
Persistent elite controllers as the key model to identify permanent HIV remission	18
Challenges towards an AIDS-free generation in Africa and Asia	15
Pulse check: modern strategies for cardiovascular risk in women with detection and prevention in women with HIV	14
Current insight into HIV-1 persistence from single-cell transcriptome profiling in acutely treated cohorts of infection	14
Estrogen depletion and immune activation and inflammation in women with HIV	14
Defining multimorbidity in people with HIV – what matters most?	14

Public health surveillance and outbreak preparedness for mpox	14
Balancing polypharmacy and comorbidity management: cardiovascular health	14
Impact of coronavirus disease 2019 on co-morbidities in HIV	13
Role of follicular homing natural killer cells in HIV infection	13
The origins of new SARS-COV-2 variants in immunocompromised individuals	13
Editorial introduction	13
Viral and immune predictors of HIV posttreatment control	13
Hepatitis co-infection in paediatric HIV: progressing treatment and prevention	13
Integrating substance use services into HIV care: an underused implementation science opportunity	13
Stigma as a facilitator of the 2022 mpox outbreak	13
New vector and vaccine platforms: mRNA, DNA, viral vectors	12
Aging of adult lifetime survivors with perinatal HIV	12
The multifaceted nature of HIV tissue reservoirs	12
Mpox and the impact on people with HIV	12
Broadly neutralizing antibodies for HIV treatment and cure approaches	11
Obesity among women with HIV	11
Gender and sex considerations in HIV and bone health	11
Metabolic dysfunction-associated steatotic liver disease in people with HIV	11
Beyond criminalization: reconsidering HIV criminalization in an era of reform	11
Frailty in people with HIV: a geriatric syndrome approach to aging with HIV	11
Single-cell sequencing technologies: a multiomics toolbox for investigating HIV-1 persistence	10
Roadmap for spatial transcriptomics of HIV in tissues	10
Single-cell multiomic understanding of HIV-1 reservoir at epigenetic, transcriptional, and protein levels	10
Editorial: New drugs for HIV: quo vadis?	9
The severity of COVID-19 across the spectrum of HIV	9
Host factors predisposing to kidney disease in people with HIV	9
Harnessing innate immunity: natural killer cells and innate immune responses in reservoir clearance	9
Maintain the gains: methods to evaluate the sustainability and scalability of HIV-related prevention, care, and treatment programs	9
Use of implementation theories, models, and frameworks in PrEP implementation research from 2022–2025: innovation and participation	9
HIV and cardiovascular disease: the role of inflammation	9
Persistent HIV-1 transcription during ART: time to reassess its significance?	8
Editorial introductions	8
Editorial introduction	8
HIV drug resistance in various body compartments	8
Innovative models of care supporting people aging with HIV	8
CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies	8
Strategies to target the central nervous system HIV reservoir	8
Guiding HIV-1 vaccine development with preclinical nonhuman primate research	7
Adolescents and young adults with HIV and unsuppressed viral load: where do we go from here?	7
The pathogenesis of obesity in people living with HIV	7
Contemporary issues in gynecologic and reproductive health for women with HIV	7
Causes and outcomes of hepatic fibrosis in persons living with HIV	7
Editorial: Is it time to implement injectable antiretroviral treatments globally?	6
Vaccinal effect of HIV-1 antibody therapy: dream or reality?	6
Whole person HIV services: a social science approach	6
Editorial introductions	6
Hepatitis C elimination in people with HIV: progress, gaps, and future directions	6
HIV-1 subtypes and latent reservoirs	6
Editorial introductions	6
How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?	6